{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "3",
          "submission_status": "AP",
          "submission_status_date": "20250609",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "82529",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761309s003lbl.pdf",
              "date": "20250610",
              "type": "Label"
            },
            {
              "id": "82530",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761309s003lbl.pdf#page=21",
              "date": "20250610",
              "type": "Medication Guide"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20230615",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "74501",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761309s000lbl.pdf",
              "date": "20230616",
              "type": "Label"
            },
            {
              "id": "74773",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761309Orig1s000ltr.pdf",
              "date": "20230718",
              "type": "Letter"
            },
            {
              "id": "75002",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/761309Orig1s000TOC.html",
              "date": "20230718",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20251027",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "83940",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761309s004lbl.pdf",
              "date": "20251028",
              "type": "Label"
            },
            {
              "id": "83961",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761309Orig1s004ltr.pdf",
              "date": "20251028",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "BLA761309",
      "sponsor_name": "GENENTECH INC",
      "openfda": {
        "application_number": [
          "BLA761309"
        ],
        "brand_name": [
          "COLUMVI"
        ],
        "generic_name": [
          "GLOFITAMAB"
        ],
        "manufacturer_name": [
          "Genentech, Inc."
        ],
        "product_ndc": [
          "50242-125",
          "50242-127"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "GLOFITAMAB"
        ],
        "rxcui": [
          "2639786",
          "2639792",
          "2639794",
          "2639795"
        ],
        "spl_id": [
          "5e794f49-9344-4145-82e3-c2f7f96988c5"
        ],
        "spl_set_id": [
          "3516e753-f064-4d30-9bd5-e3f2e143f75d"
        ],
        "package_ndc": [
          "50242-127-01",
          "50242-125-01"
        ],
        "nui": [
          "N0000194063",
          "N0000175078",
          "N0000175617",
          "N0000175618",
          "N0000009267",
          "N0000182136"
        ],
        "pharm_class_epc": [
          "Bispecific CD20-directed CD3 T Cell Engager [EPC]"
        ],
        "pharm_class_moa": [
          "CD20-directed Antibody Interactions [MoA]",
          "CD3-directed Antibody Interactions [MoA]",
          "CD3 Receptor Agonists [MoA]",
          "Cytochrome P450 Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Increased Cytokine Activity [PE]"
        ],
        "unii": [
          "06P3KLK2J8"
        ]
      },
      "products": [
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "COLUMVI",
          "active_ingredients": [
            {
              "name": "GLOFITAMAB-GXBM",
              "strength": "10MG/10ML(1MG/ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "COLUMVI",
          "active_ingredients": [
            {
              "name": "GLOFITAMAB-GXBM",
              "strength": "2.5MG/2.5ML(1MG/ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}